Abstract

BackgroundLong-term data on drug survival of TNF inhibitors (TNFi) in the treatment of spondyloarthropathies are still lacking.ObjectivesThe aim of the study is to analyze in a setting of real-life the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0959 SECUKINUMAB SURVIVAL AND ASSOCIATED DEMOGRAPHIC CHARACTERISTICS IN PATIENTS WITH SPONDYLOARTHRITIS AND PSORIASIC ARTHRITIS IN A REAL CLINICAL SETTING
L Ibarrola ... C Fito-Manteca
Annals of the Rheumatic Diseases | VOL. 82
L Ibarrola, et. al.L Ibarrola ... C Fito-Manteca
30 May 2023
AB0945 ASSESSMENT OF THE RISK OF LIVER FIBROSIS IN SPONDYLOARTHRITIS TREATED WITH SECUKINUMAB: A SINGLE-CENTER RETROSPECTIVE OBSERVATIONAL STUDY
F Verhoeven ... D Wendling
Annals of the Rheumatic Diseases | VOL. 82
F Verhoeven, et. al.F Verhoeven ... D Wendling
30 May 2023
Ultrasonographic Evaluation of Nail Involvement in Patients With Axial Spondyloarthritis.
Kenan Akgun ... Tugce Ozekli Misirlioglu
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine | VOL. 43
Kenan Akgun, et. al.Kenan Akgun ... Tugce Ozekli Misirlioglu
07 Feb 2024
THU0394 THE PREVALENCE OF EXTRA-ARTICULAR MANIFESTATIONS IN AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS IS ASSOCIATED TO DISEASE DURATION: RESULTS FROM THE LEEDS SPECIALIST SPONDYLOARTHRITIS SERVICE
Sayam Dubash ... Xabier Michelena-Vegas
-
Sayam Dubash, et. al.Sayam Dubash ... Xabier Michelena-Vegas
01 Jun 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers